期刊文献+

5-氟尿嘧啶明胶微球的制备、表征及释药性能 被引量:7

Preparation, Characterization and Drug Release Property of 5-Fluorouracil Gelatin Microspheres
在线阅读 下载PDF
导出
摘要 为了获得粒径为50~100μm的5-氟尿嘧啶/明胶微球(5-Fu/GMs),采用乳化一化学交联法,讨论了5-Fu用量、乳化剂浓度和水/油比等因素对微球平均粒径、载药量及包封率等的影响。结果表明,5-Fu/明胶质量比为0.5,乳化剂浓度为0.5%和水/油相体积比为1/10时,可获得最大的载药量30.1%和包封率90.2%。体外释药性能表明5-氟尿嘧啶明胶微球具有明显的药物缓释作用。 In order to obtain the 50-100μm of 5-fluorouracil/gelatin microspheres(5-Fu/GMs), emulsion chemical crosslinking method was used. The impacts of 5-Fu contents, surfactant concentration and W/O phase ratio on mean size, drug content, encapsulation efficiency of 5-Fu/GMs were studied. The results showed that 5-Fu/GMs had the drug content 30.1% and the encapsulation efficiency 90.2 %, when 5-Fu/gelatin(w/w), surfactant concentration and W/O(v/v) respectively were 0.5, 0.5 % and 1/10. In vitro drug release results showed that 5-Fu/GMs could prolong 5-Fu release evidently.
出处 《广东化工》 CAS 2009年第5期117-119,145,共4页 Guangdong Chemical Industry
基金 华中科技大学校科学研究基金(20073017)
关键词 乳化-化学交联法 明胶微球 5-氟尿嘧啶 体外释放 emulsion chemical crosslinking method gelatin microspheres 5-fluorouracil in-vitro drug release
  • 相关文献

参考文献8

二级参考文献23

  • 1田景振,邱海霞,刘瑾,梅兴国.氟尿嘧啶聚乳酸微球在PVR家兔体内的研究[J].中国医药工业杂志,2006,37(2):106-109. 被引量:2
  • 2陶涛 谢星辉 等.肝动脉栓塞微球的研究[J].药学学报,1988,23(1):55-55.
  • 3Sakane T,Yamashita S,Yata H,et al.Transnasal delivery of 5-fluorouracil to the brain in the rat[J].J Drug Targeting,1999,7(3):233-239.
  • 4Lim ST,Mrtin GP,Berry DJ,et al.Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan[J].J of Controlled Release,2000,66:281-292.
  • 5Denkbas EB,Seyyal M,Piskin E.Implantable 5-fluorouracil loaded chitosan scaffolds prepared by wet spinning[J].J of Membrane Science,2000,172:33-38.
  • 6Illum L,Jorgensed H,Bisgaard H,et al.Bioadhesive microspheres as a potential nasal drug delivery system[J].Int J Pharm,1987,39(3):189-195.
  • 7Sheu MT,Sokoloski TD.Entrapment of bioactive compounds within native albumin beads:Ⅲ.Evaluation of parameters affecting drug release[J].J Parenter Sci Technol,1986,40(6):259-266.
  • 8LUBBE AS, ALEXION C, BERGEMANN C. Clinical application of magnetic drug targeting[J]. J Surg Res, 2001, 95(2): 200-206.
  • 9GUPTA PK, HUNG CT. Magnetically controlled targeted micro-carrier systems[J]. Life Sci, 1989, 44: 175-186.
  • 10WIDDER KJ, MORINO PA, MORRIS RM, et al. Selective targeting of magnetic albumin microspheres to th yoshida sarcoma: ultrastructural evaluation of microspheres disposition [J]. Eur J Cancer Clin Oncol, 1983, 19: 141-147.

共引文献87

同被引文献82

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部